Evidence map›Paper›PMID 40678107›Full record

ArticleAJOG global reports2025

Corrigendum to 'Safety of quadrivalent recombinant influenza vaccine in pregnant persons and their infants' [AJOG Global Reports Volume 4, Issue 4, November 2024, 100395].

Amber Hsiao, Arnold Yee, Ruvim Izikson, Bruce Fireman, John Hansen, Ned Lewis, Sonja Gandhi-Banga, Alexandre Selmani, Oxana Talanova, Heidi Kabler and 2 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in AJOG global reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Amber HsiaoKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).
Arnold YeeKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).
Ruvim IziksonSanofi, Swiftwater, Pennsylvania, PA, USA (Izikson, Selmani, Talanova, Kabler, and Inamdar).
Bruce FiremanKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).
John HansenKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).
Ned LewisKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).
Sonja Gandhi-BangaSanofi, Toronto, Ontario, Canada (Gandhi-Banga).
Alexandre SelmaniSanofi, Swiftwater, Pennsylvania, PA, USA (Izikson, Selmani, Talanova, Kabler, and Inamdar).
Oxana TalanovaSanofi, Swiftwater, Pennsylvania, PA, USA (Izikson, Selmani, Talanova, Kabler, and Inamdar).
Heidi KablerSanofi, Swiftwater, Pennsylvania, PA, USA (Izikson, Selmani, Talanova, Kabler, and Inamdar).
Ajinkya InamdarSanofi, Swiftwater, Pennsylvania, PA, USA (Izikson, Selmani, Talanova, Kabler, and Inamdar).
Nicola P KleinKaiser Permanente Vaccine Study Center, Oakland, CA, USA (Hsiao, Yee, Fireman, Hansen, Lewis, and Klein).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.xagr.2024.100395.].

Identifiers

PMID40678107
PMCPMC12269616

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.